24°C
30°C
23.6°C
Journal
- The Lancet. COVID-19 Resource Centre
- The New England Journal of Medicine (NEJM). Coronavirus (Covid-19)
- JAMA. Coronavirus Disease 2019 (COVID-19)
- BMJ. Coronavirus Disease 2019 (COVID-19)
- British Society for Antimicrobial Chemotherapy. COVID-19: Resource Hub
- National Institutes of Health. LitCovid
- Cochrane Library. Coronavirus (COVID-19)
- Imperial College. COVID-19 reports
- Infectious Diseases Society of America (IDSA). COVID-19 Resource Center
- Elsevier Covid-19 Healthcare Hub
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings (2021 October 7).
- SARS-CoV-2 RNAemia and clinical outcomes in children with COVID-19 (2021 October 7).
- Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition (2021 October 6).
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study (2021 October 4).
- The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study (2021 October 1).
- Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections (2021, September 29).
- Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study (2021 August 16).
- Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study (2021 August 6).
- Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study (2021 July 29).
- Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study (2021 May 10).
- 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study (2021 May 5).
- An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. (2020 July 14).
- COVID-19: Immunopathology and its implications for therapy. (2020 April 9).
- COVID-19: Consider cytokine storm syndromes and immunosuppression. (2020 March 28).
- Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. (2020 July 28).
- Dexamethasone in Hospitalized Patients with Covid-19—Preliminary Report. (2020 July 17).
- Extrapulmonary manifestations of COVID-19. (2020 July 10).
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. (2020 May 16).
- De-isolating COVID-19 Suspect Cases: A Continuing Challenge. (2020 February 26).
- Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. (2020 February 19).
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome. (2020 February 18).
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. (2020 February 15).
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. (2020 February 15).
- Novel coronavirus infection in hospitalized infants under 1 year of age in China. (2020 February 14).
- Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. (2020 February 13).
- Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. (2020 February 7).
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. (2020 January 30).
- Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. (2020 June 22).
- Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020. (2020).
- Impact of the influenza vaccine on COVID-19 infection rates and severity (2021 February 22)
- A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. (2020 November 1).
- How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre (2020 October)
- Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. (2020 July 15).
- Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. (2020 July 15).
- Increased risk of COVID-19 among users of proton pump inhibitors. (2020 July 7).
- Clinical features of fatalities in patients with COVID-19. Disaster Medicine and Public Health Preparedness. (2020).
- Patterns of antibody response to SARS-CoV-2 among 1.6 million blood donors: Impact of vaccination, United States December 2020 – June 2021 (2021 October 9).
- SARS-CoV-2 Antibody Response in Persons with Past Natural Infection (2021 July 1).
- Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19 (2021 April 22).
- Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear. (2020 July 3).
- Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. (2020 April 1).
- SARS-CoV-2 viral load in upper respiratory specimens of infected patients. (2020 February 19).
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. (2020 January 30).
- A novel coronavirus from patients with pneumonia in China, 2019. (2020 January 24).
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. (2020 January 23).
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. (2020 January 1).
► Epidemiology and Infection Control
- Joint Estimation of Generation Time and Incubation Period for Coronavirus Disease 2019 (2021 August 23).
- Providing safe care for patients in the coronavirus disease 2019 (COVID-19) era: A case series evaluating risk for hospital-associated COVID-19 (2021 April 5).
- It is time to address airborne transmission of covid-19. (2020 July 6).
- Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. (2020 May 12).
- The serial interval of COVID-19 from publicly reported confirmed cases. (2020 March 6).
- Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. (2020 March 4).
- Clinical Data on Hospital Environmental Hygiene Monitoring and Medical Staff Protection during the Coronavirus Disease 2019 Outbreak. (2020 March 2).
- Protecting health-care workers from subclinical coronavirus infection (2020 March 1).
- Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. (2020 March 1).
- Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. (2020 February 29).
- Key Points of the Program for Disinfection Technology in Special Places During the Coronavirus Disease-2019 (COVID-19) Outbreak. (2020 February 28).
- Clinical features and sexual transmission potential of SARS-CoV-2 infected female patients: a descriptive study in Wuhan, China. (2020 February 27).
- Importation and human-to-human transmission of a novel coronavirus in Vietnam. (2020 February 27).
- Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. (2020 February 6).
- Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. (2020 January 30).
- Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. (2020 January 29).
► Asymptomatic or Pre-symptomatic infections
- Estimating the Asymptomatic Proportion of 2019 Novel Coronavirus onboard the Princess Cruises Ship. (2020 March 6).
- Presumed asymptomatic carrier transmission of COVID-19. (2020 February 21).
- Investigation of a Cluster of 2019 Novel Coronavirus Disease (COVID-19) with Possible Transmission During the Incubation Period — Shenyang City, China, 2020. (2020 February 21).
- Asymptomatic cases in a family cluster with SARS-CoV-2 infection. (2020 February 19).
- Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection (2021 October).
- A systematic scoping review of COVID‐19 during pregnancy and childbirth. (2020 July).
- Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: A systematic review and critical analysis. (2020 July 22).
- Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. (2020 February 12).
► Disinfection and environmental stability
- Airborne SARS-CoV-2 is Rapidly Inactivated by Simulated Sunlight. (2020 June 11).
- Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. (2020 April 16).
- Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses. (2020 June 24).
- Stability of SARS-CoV-2 in different environmental conditions. (2020 January 1).
- PRO: the COVID-19 pandemic will result in increased antimicrobial resistance rates. (2020 July).
- CON: COVID-19 will not result in increased antimicrobial resistance prevalence. (2020 July).
- Tackling antimicrobial resistance in the COVID-19 pandemic. (2020 July 1).
- Impact of COVID-19 on traditional healthcare-associated infection prevention efforts. (2020 April 16).
Top